The biomedical model of health is the dominant framework in Western medicine that defines health as the absence of disease and explains disease as a malfunction in the body’s biological machinery. Under this model, every illness has a specific physical cause, whether a pathogen, a genetic mutation, or a biochemical imbalance, and the clinician’s job is to identify that cause, target it with treatment, and restore the body to normal. The approach has driven extraordinary advances in surgery, pharmacology, and infectious disease control, but its tight focus on biology leaves out much of what shapes whether people get sick and how they experience illness.
Where the Model Came From
The biomedical model did not spring up overnight. Its philosophical roots trace back to a seventeenth-century idea that the mind and body are essentially separate entities. That separation gave early scientists permission to study the body as a physical system, much like a machine whose parts could be inspected and repaired independently. Critics have argued that this philosophical stance is partly responsible for medicine’s long-standing blind spot toward the psychological and social dimensions of illness.
Two historical developments cemented the model’s authority. First, the emergence of germ theory in the nineteenth century gradually replaced older beliefs that diseases were intrinsic or caused by “bad air.”1PubMed Central. The genetic theory of infectious diseases: a brief history and selected illustrations Once researchers could identify specific microorganisms behind cholera, tuberculosis, and other killers, the logic of “one disease, one cause, one cure” became deeply persuasive. Second, the Flexner Report of 1910 transformed medical education in the United States, standardizing curricula around laboratory science and establishing the biomedical model as the gold standard of medical training.2PubMed Central. The Flexner Report–100 years later Medical schools that could not meet the new scientific benchmarks were shut down, and the ones that survived were rebuilt around anatomy, physiology, biochemistry, and pathology.3PubMed Central. The Impact and Implications of the Flexner Report on Medical Education in Korea
The result was a profession organized around a powerful but narrow assumption: if you can find the broken part, you can fix the patient.
Core Assumptions
The biomedical model rests on a handful of interlocking ideas that, taken together, shape how most doctors are trained to think about your health.
- Disease as deviation: Health is treated as the normal state, and disease is defined as a measurable departure from normal biological values, whether that is a blood glucose level, a tumor on a scan, or a bacterial culture result.4PubMed Central. Do biomedical models of illness make for good healthcare systems?
- Reductionism: Complex conditions are broken down into their smallest components. The expectation is that by isolating individual causal factors and studying them separately, you can understand and treat the whole.5Rethinking Causality, Complexity and Evidence for the Unique Patient. Complexity, Reductionism and the Biomedical Model
- Mind-body separation: The body is treated as a biological machine largely independent of the mind. Mental states such as stress, grief, or hope are treated as secondary to, and separate from, the physical processes of disease.6PubMed Central. Mind-body Dualism: A critique from a Health Perspective
- Specific etiology: Every disease has a specific, identifiable cause. Treatment means neutralizing that cause, whether through antibiotics, surgery, or a targeted drug.
These assumptions work beautifully for a broken bone or a strep throat infection. They become far less reliable when applied to conditions that do not have a single identifiable cause, which turns out to include most of what actually makes people sick in wealthy countries today.
What the Model Does Well
There is a reason the biomedical model became dominant: it works spectacularly in many contexts. Vaccines, antibiotics, antiseptic surgery, organ transplantation, and targeted cancer therapies are all products of the model’s core logic. When a disease really does have a discrete biological cause and a specific treatment can reverse it, the biomedical approach is hard to beat.
The reductionist approach also fueled the modern pharmaceutical industry. Advances in molecular biology, genomics, and robotics allowed researchers to screen huge libraries of chemical compounds against specific biological targets, with the expectation that drug discovery would become faster and cheaper.7PubMed Central. The inadequacy of the reductionist approach in discovering new therapeutic agents against complex diseases For certain diseases, that expectation was justified. Drugs targeting specific enzyme deficiencies, hormone receptors, or viral proteins have saved millions of lives.
Public health campaigns rooted in biomedical thinking, such as sanitation reforms and vaccination programs, drove down mortality from infectious diseases throughout the twentieth century. The logic was simple and effective: identify the pathogen, block transmission, and the disease disappears from the population. Smallpox was eradicated, polio was brought to the brink of elimination, and childhood mortality dropped sharply across the globe.
Where the Model Falls Short
The trouble starts when you try to apply the same “find the broken part” logic to conditions that do not behave like infections. Chronic pain is a vivid example. A narrative review in the journal Cureus argued that the biomedical model’s reductionist vision is inadequate for understanding and treating chronic pain, because the condition involves a tangle of biological, psychological, and social factors that cannot be separated into neat cause-and-effect chains.8PubMed Central. Beyond the Biomedical Model: A Critical Review of the Approach to Chronic Pain and the Proposal of an Integrated Functional Model Someone with chronic lower back pain might have imaging that looks perfectly normal, or imaging that shows abnormalities common in people who feel no pain at all. The biomedical model’s insistence on finding the physical lesion can lead to unnecessary surgeries, overuse of opioids, and patients feeling dismissed when no lesion is found.
The model also struggles with the gap between disease and illness. In medical anthropology, “disease” refers to the objective biological malfunction a doctor can measure, while “illness” refers to the subjective experience of feeling unwell and how a person and their family perceive, interpret, and respond to symptoms.9PubMed Central. Health, Disease, and Illness as Conceptual Tools Two people with the same lab results can have wildly different experiences of their condition, depending on their psychological state, their social support, their cultural background, and their economic circumstances. The biomedical model, which focuses exclusively on the measurable deviation, has no built-in way to account for this.
This is not a minor gap. Think of someone with well-controlled type 2 diabetes whose blood sugar numbers look fine on paper but who is struggling with depression, food insecurity, and the daily stress of managing a chronic condition. From a strictly biomedical standpoint, the treatment is working. From the patient’s standpoint, they are not well. A model that defines health purely as the absence of measurable pathology cannot see what is happening to that person.
Engel’s Challenge and the Biopsychosocial Alternative
The most famous critique of the biomedical model came from the psychiatrist George Engel in a landmark 1977 paper in the journal Science. Engel argued that the dominant model of disease left no room for the social, psychological, and behavioral dimensions of illness, and he proposed a biopsychosocial model as a broader framework for research, teaching, and clinical care.10PubMed. The need for a new medical model: a challenge for biomedicine The idea was not to throw out biology but to insist that biology alone is never the full picture. A more recent paper described the biopsychosocial model as an improvement to the biomedical model, designed to account for psychological and social factors alongside biological ones.11PubMed Central. A revitalized biopsychosocial model: core theory, research paradigms, and clinical implications
The biopsychosocial model has been widely adopted in medical school curricula and clinical guidelines, at least on paper. In practice, the biomedical model still dominates how most clinical encounters unfold. Time pressures, insurance reimbursement structures, and the sheer institutional momentum of a system built around diagnosis codes and lab values mean that the biological dimension almost always gets the most attention. Engel’s critique was persuasive, but nearly half a century later, the biomedical model has proven remarkably resistant to replacement.
The Problem in Mental Health
Nowhere is the tension between the biomedical model and lived reality more apparent than in psychiatry. The standard classification systems for mental disorders treat conditions as largely discrete entities characterized by distinctive signs, symptoms, and natural histories, much the way medical diagnoses work for physical diseases.12PubMed Central. Clashing Diagnostic Approaches: DSM-ICD Versus RDoC Depression gets a code. Anxiety gets a different code. Each is assumed to be a distinct category with identifiable boundaries.
But the categories do not hold up the way biomedical logic expects them to. Critiques of psychiatric diagnosis point to problems with reliability (how often two clinicians agree on the same diagnosis), validity (whether diagnostic categories truly reflect distinct conditions), and the high rates at which diagnoses overlap in the same patient.13The Medical Model in Mental Health. Criticism of psychiatric diagnosis Many psychiatric diagnoses lack clear biological markers, and the categories can carry negative consequences like stigma while implying an inaccurate picture of mental health problems as straightforward diseases.
Treatment faces similar questions. Psychiatric medications are often prescribed because clinical trials showed they worked in a given situation, even when the mechanism of action remains unclear.14The Medical Model in Mental Health. Criticism of psychiatric treatment That is not necessarily different from other areas of medicine, where treatments sometimes work without a fully understood mechanism, but it does undermine the biomedical model’s foundational claim that treatment targets a known biological cause. The honest picture in much of psychiatry is more pragmatic: we use what seems to help, and the tidy biological narrative often comes after the fact.
Medicalization and Its Consequences
One under-discussed side effect of the biomedical model is medicalization, the historical process by which personal, behavioral, and social issues are increasingly viewed through a biomedical lens and treated as individual pathologies by medical authorities.15PubMed Central. The Perils of Medicalization for Population Health and Health Equity Shyness becomes social anxiety disorder. Grief becomes major depressive disorder. Childhood energy becomes attention deficit hyperactivity disorder. Not all of these reclassifications are wrong, but the drift toward biomedical framing can obscure the social, political, and economic conditions that contribute to suffering.
When “health” becomes synonymous with “health care,” as medicalization encourages, the response to a community’s poor health outcomes tends to be more clinics and more prescriptions rather than cleaner water, safer housing, or better wages. The biomedical model of health, by locating the problem inside the individual body, makes it easy to overlook the structural conditions that make bodies sick in the first place. A person’s zip code is often a stronger predictor of their life expectancy than their genetic profile, but the biomedical model has no natural way to account for that.
The Pharmaceutical Industry and Biomedical Incentives
The biomedical model does not exist in a vacuum. It is reinforced by an economic ecosystem that rewards finding and selling targeted biological interventions. Roughly nine out of ten dollars that pharmaceutical companies spend on advertising go to physicians and other prescribers, and industry payments to doctors and teaching hospitals in the United States alone reached about $3.6 billion in 2019.16PubMed Central. Interaction between physicians and the pharmaceutical industry: A scoping review for developing a policy brief Close to half of all physicians receive annual payments from the industry, and research has shown that increases in these payments are associated with higher medical and drug costs.16PubMed Central. Interaction between physicians and the pharmaceutical industry: A scoping review for developing a policy brief
None of this means that pharmaceutical products are inherently bad. Many are lifesaving. But the financial incentives powerfully reinforce the biomedical assumption that the right response to illness is a targeted biological product. Lifestyle interventions, community health programs, and psychosocial support rarely have a comparable marketing budget behind them. When the model and the money both point in the same direction, alternative approaches struggle to gain traction even when the evidence supports them.
Other Ways of Thinking About Health
The biomedical model is not the only game in town, and several alternative frameworks offer different starting points. The salutogenesis model, for instance, flips the question entirely. Instead of asking “What causes disease?” it asks “What creates health?” The focus shifts to the factors responsible for well-being rather than disease pathogenesis.17PubMed Central. Salutogenesis: A bona fide guide towards health preservation Under this framework, a strong sense of coherence, social connections, and meaningful daily activity are not just nice extras but core health resources.
Traditional Chinese medicine offers yet another lens, one that predates the biomedical model by millennia. Research has identified areas where traditional Chinese medicine overlaps with modern biomedical understanding, areas where it goes beyond what modern medicine has validated, and areas that still need further evaluation.18PubMed Central. The Relationship between Traditional Chinese Medicine and Modern Medicine The broader point is that the biomedical model represents one historically and culturally specific way of organizing medical knowledge, not the only possible way. Billions of people around the world use health systems that operate on fundamentally different assumptions about the relationship between the body, the mind, the community, and the environment.
Patient-Centered Care and Shared Decision-Making
One of the practical consequences of the biomedical model’s dominance has been a paternalistic style of clinical care. When the doctor’s job is to diagnose the biological problem and prescribe the biological fix, the patient’s role shrinks to compliance. Patient-centered care emerged as a corrective, commonly framed as a way to guard against the “doctor knows best” attitude that the biomedical model naturally encourages.19PubMed Central. Reconsidering patient-centred care: Authority, expertise and abandonment
Shared decision-making asks clinicians to assess the preferences of patients and their families and to offer them real participation in treatment choices.20PubMed. Medical decision making: paternalism versus patient-centered (autonomous) care This matters because two patients with the same diagnosis may have very different priorities. One person with early-stage prostate cancer might choose active surveillance to preserve quality of life; another might choose surgery because the anxiety of waiting would be worse for them than the side effects of the operation. The biomedical model, on its own, has nothing to say about that choice, because it only sees the tumor. Making room for the patient’s values and circumstances requires stepping outside the model’s boundaries, even while relying on its diagnostic tools.
Personalized Medicine and the Model’s Evolution
Paradoxically, one of the most biomedical developments in recent years, the rise of personalized medicine, is also pushing the model to evolve. By integrating data from genomics, proteomics, metabolomics, and other molecular profiles, researchers aim to tailor treatments to the individual rather than relying on one-size-fits-all protocols.21PubMed Central. Revolutionizing Personalized Medicine: Synergy with Multi-Omics Data Generation, Main Hurdles, and Future Perspectives The promise is that therapies become more precise and side effects less common when treatment accounts for your specific molecular makeup.
This is still fundamentally biomedical, focused on biology at the molecular level. But it represents a shift away from the older version of the model, which assumed that a disease looks the same in every body. Personalized medicine acknowledges that the same diagnosis can behave differently in different people, which is an opening for recognizing the complexity that critics like Engel pointed to decades ago. Whether that opening widens enough to incorporate psychological and social dimensions remains an open question. The technology is advancing rapidly, but the underlying philosophy of “find the broken molecule and fix it” has not yet given way to something broader. The most honest description of where things stand is that the biomedical model is becoming more sophisticated without necessarily becoming less reductionist.